AR116010A1 - ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM - Google Patents

ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM

Info

Publication number
AR116010A1
AR116010A1 ARP190102409A ARP190102409A AR116010A1 AR 116010 A1 AR116010 A1 AR 116010A1 AR P190102409 A ARP190102409 A AR P190102409A AR P190102409 A ARP190102409 A AR P190102409A AR 116010 A1 AR116010 A1 AR 116010A1
Authority
AR
Argentina
Prior art keywords
methods
escherichia coli
compositions
modified
coli
Prior art date
Application number
ARP190102409A
Other languages
Spanish (es)
Inventor
Wei Chen
Nishith Merchant
Karen Kiyoko Takane
Scott Ellis Lomberk
Ling Chu
Suddham Singh
Mark Edward Ruppen
Avvari Krishna Prasad
Rosalind Pan
Justin Keith Moran
Jason Arnold Lotvin
Srinivas Kodali
Jin Kim
- Gu Jianxin Hwan
Laurent Oliver Chorro
Annaliesa Sybil Anderson
Robert G K Donald
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR116010A1 publication Critical patent/AR116010A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Una composición inmunógena que comprende moléculas de polisacárido O modificadas derivadas de lipopolisacáridos de E. coli y conjugados de estos. Se pueden preparar vacunas multivalentes mediante la combinación de dos o más composiciones inmunógenas monovalentes para diferentes serotipos de E. coli. Las moléculas de polisacárido O modificadas son producidas por una bacteria recombinante que incluye un gen wzz.An immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines can be prepared by combining two or more monovalent immunogenic compositions for different serotypes of E. coli. The modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.

ARP190102409A 2018-08-24 2019-08-23 ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM AR116010A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862722370P 2018-08-24 2018-08-24

Publications (1)

Publication Number Publication Date
AR116010A1 true AR116010A1 (en) 2021-03-25

Family

ID=75905144

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102409A AR116010A1 (en) 2018-08-24 2019-08-23 ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM

Country Status (1)

Country Link
AR (1) AR116010A1 (en)

Similar Documents

Publication Publication Date Title
CO2021001926A2 (en) Escherichia coli compositions and methods
EA201691478A1 (en) NEW POLYSACCHARIDE AND ITS APPLICATIONS
CY1121535T1 (en) USPA2 PROTEIN PRODUCTS AND THEIR USES
BR112018003469A2 (en) composition, method for inducing an immune response to e.g. extraintestinal pathogenic coli, and, process for producing a composition.
BR112017015789A2 (en) bivalent swine influenza virus vaccine
EA201790294A1 (en) FLAGELLIN BASED MEANS AND APPLICATIONS INCLUDING EFFECTIVE VACCINATION
CL2019003805A1 (en) Senecavirus a Immunogenic Compositions and Methods of These.
MX2020004543A (en) Zika vaccines and immunogenic compositions, and methods of using the same.
UY33297A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME
BR112018075440A2 (en) compositions and methods for preventing and treating Zika virus infection
MA46661B1 (en) GLYCOCONJUGATE VACCINE FORMULATIONS DIRECTED AGAINST EXPEC
BR112018076234A2 (en) infectious bronchitis virus vaccine
EA201690859A1 (en) PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS, GLYOPROTEIN VACCINES SYNTHESIZED IN ESCHERICHIA COLI
ME00982B (en) Attenuated mycoplasma gallisepticum strains
BR112018015453A2 (en) attenuated infectious bronchitis virus
BR112018074910A2 (en) immunological composition, and method of inducing an immune response against equine influenza virus in a subject
EA202191145A1 (en) VACCINE VIB 4/91 WITH HETEROLOGICAL SPINE PROTEIN
EA201892003A1 (en) TREATMENT OF ATOPIC DERMATITIS DOGS
EA202191147A1 (en) VIB H52 VACCINE WITH HETEROLOGICAL SPINE PROTEIN
AR116010A1 (en) ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM
BR112022019207A2 (en) VACCINE COMPOSITIONS FOR CORONA VIRUSES AND METHODS OF THEIR USE
PL404229A1 (en) Isolated immunogenic bacterial antigen and its use in the prevention and treatment of infections caused by Gram-negative bacteria
BR112015018330A2 (en) live modified flavobacterium strains, stabilized vaccines comprising them, and methods for preparing and using them
EA202090236A1 (en) IMMUNOGENIC COMPOSITIONS OF SENECAVIRUS A AND WAYS WITH THEM
BR112018071176A2 (en) rapid method of producing live attenuated vaccines